 |
By (user no longer on site) OP
over a year ago
|
According to king’s college after 3 weeks there appears to be 68% efficacy after the first dose going off data from their Zoe survey.
https://youtu.be/vReTwfEithg
|
Reply privately, Reply in forum +quote
or View forums list | |
|
By *obka3Couple
over a year ago
bournemouth |
Please stop posting good news it will upset the doom sayers. We should be over the worst now, summer coming, vaccine numbers huge and increasing and better treatments are all positve, we now need to spend our money in the UK to help the economy. |
Reply privately, Reply in forum +quote
or View forums list | |
Sounds like that figure is for the Pfizer-BioNTech vaccine only, as the video states they are "still cleaning up the data on the Oxford-AZ vaccine".
I'm very interested as to what the efficacy is after the 12 week period on one dose (so beyond that studied by Pfizer) and also very keen to see it broken down by age.
I don't know what you age range is of the ZOE study, but the fact it's a daily app reporting thing, I'd suggest a very small number of older people (say, over 70/75) are contributing. These are the highest risk people but also likely to make the weakest immune response.
Very interested in the full report  |
Reply privately, Reply in forum +quote
or View forums list | |
|
By (user no longer on site) OP
over a year ago
|
"Sounds like that figure is for the Pfizer-BioNTech vaccine only, as the video states they are "still cleaning up the data on the Oxford-AZ vaccine".
I'm very interested as to what the efficacy is after the 12 week period on one dose (so beyond that studied by Pfizer) and also very keen to see it broken down by age.
I don't know what you age range is of the ZOE study, but the fact it's a daily app reporting thing, I'd suggest a very small number of older people (say, over 70/75) are contributing. These are the highest risk people but also likely to make the weakest immune response.
Very interested in the full report "
At 4.5 million users I’d say it’s the biggest survey. |
Reply privately, Reply in forum +quote
or View forums list | |
"Sounds like that figure is for the Pfizer-BioNTech vaccine only, as the video states they are "still cleaning up the data on the Oxford-AZ vaccine".
I'm very interested as to what the efficacy is after the 12 week period on one dose (so beyond that studied by Pfizer) and also very keen to see it broken down by age.
I don't know what you age range is of the ZOE study, but the fact it's a daily app reporting thing, I'd suggest a very small number of older people (say, over 70/75) are contributing. These are the highest risk people but also likely to make the weakest immune response.
Very interested in the full report
At 4.5 million users I’d say it’s the biggest survey."
The video said a third of a million have submitted data about a vaccine. It's still potentially skewed towards age groups more likely to use apps on a smartphone daily. |
Reply privately, Reply in forum +quote
or View forums list | |
» Add a new message to this topic
